29 active trials 9 recruiting 6 Phase 3 7 disease areas 1 changes in 30 days
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Daewoong Pharmaceutical Co. LTD.Phase 1 NCT06592495 Registry history of NCT06592495 on ClinicalTrials.gov (opens the registry)
Changed
| Phase 1 | 7 | |
| Phase 2 | 1 | |
| Phase 3 | 6 | |
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07533266 | Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced… | NSAID (Non-Steroidal Anti-Inflammatory Drug) | Not Yet Recruiting | 2026-04-16 |
| Phase 3 | ||||
| NCT07783763 | Study of DWP450 in Japanese Subjects With Glabellar Lines | Glabellar Lines | Not Yet Recruiting | 2026-08-26 |
| NCT07746518 | Efficacy and Safety of DWP14012 for Long-Term Maintenance Therapy in Patients With Healed… | Healed Erosive Esophagitis | Not Yet Recruiting | 2026-08-13 |
| NCT07730138 | Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric Ulcer | Gastric Ulcer | Not Yet Recruiting | 2026-07-28 |
| NCT07619833 | To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and… | T2DM (Type 2 Diabetes Mellitus) | Not Yet Recruiting | 2026-06-02 |
| NCT07013279 | Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines | Glabellar Lines | Not Yet Recruiting | 2025-06-10 |
| NCT06606093 | Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate… | Type 2 Diabetic Nephropathy | Not Yet Recruiting | 2024-09-20 |
| Phase 2 | ||||
| NCT05389215 | Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF | Idiopathic Pulmonary Fibrosis | Active, Not Recruiting | 2026-07-16 |
| Phase 1 | ||||
| NCT07539415 | A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to… | Obesity & Overweight | Recruiting | 2026-07-16 |
| NCT06736587 | Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and… | Autoimmune Diseases | Recruiting | 2026-06-08 |
| NCT07371104 | Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian… | Cancer | Recruiting | 2026-05-08 |
| NCT07260851 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and… | Healthy Volunteers | Recruiting | 2025-12-17 |
| NCT07267221 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and… | Healthy Volunteers | Recruiting | 2025-12-05 |
| NCT07144176 | PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers | Healthy Subjects | Recruiting | 2025-08-28 |
| NCT06644404 | Phase 1 Study of Drug-Drug Interactions Between DWP16001, DWC202407, and DWC202408 in… | Healthy | Not Yet Recruiting | 2024-10-16 |
| Not applicable | ||||
| NCT07516977 | Noseguard for Prevention of Respiratory Infections in Real-World Use | Respiratory Infection Virus | Not Yet Recruiting | 2026-04-08 |
| Not specified | ||||
| NCT07515599 | Observational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure… | Stage 1 Hypertension | Recruiting | 2026-04-07 |
| NCT06948487 | Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis | Gastritis | Recruiting | 2025-07-17 |
| NCT06647888 | Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension… | Diabetes Mellitus, Type 2 | Recruiting | 2025-01-23 |
| NCT07558707 | Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World Practice | Peptic Ulcer | Not Yet Recruiting | 2026-04-30 |
| NCT07515560 | Efficacy and Safety of Baroezet Tablet in Korean Patients With Dyslipidemia: A… | Dyslipidemia | Not Yet Recruiting | 2026-04-07 |
| NCT07190391 | Phase 4 Multicenter, Open-label Study on Efficacy and Safety of Apremilast in… | Psoriasis | Not Yet Recruiting | 2025-09-24 |
| NCT05926414 | To Evaluate the Efficacy and Safety of Envlo Tablet or Envlomet SR Tablet in Patients… | Diabetes Mellitus, Type 2 | Active, Not Recruiting | 2025-09-02 |
| NCT06419816 | Effect of Linking Data Using Smartphone Application, 'Well Check', on Clinical Outcomes… | Type 2 Diabetes | Active, Not Recruiting | 2025-09-02 |
| NCT06427083 | Registry Study to Determine the Effectiveness and Safety of Weight Loss With… | Type 2 Diabetes Mellitus | Active, Not Recruiting | 2025-09-02 |
Diabetes (6) · Type 2 Diabetes (6) · Hypertension (3) · Idiopathic Pulmonary Fibrosis (1) · Obesity (1) · Ovarian Cancer (1) · Psoriasis (1)